-
Loading metrics
Open Access
Peer-reviewed
Research Article
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma
-
Giselle L. Saulnier Sholler ,
* E-mail: giselle.sholler@helendevoschildrens.org (GS) or andre.bachmann@hc.msu.edu (AB)
Affiliations Helen DeVos Children’s Hospital, Grand Rapids, Michigan, United States of America, College of Human Medicine, Michigan State University, Grand Rapids, Michigan, United States of America
⨯ -
Eugene W. Gerner,
Affiliation Cancer Prevention Pharmaceuticals, Tucson, Arizona, United States of America
⨯ -
Genevieve Bergendahl,
Affiliation Helen DeVos Children’s Hospital, Grand Rapids, Michigan, United States of America
⨯ -
Robert B. MacArthur,
Affiliation Cancer Prevention Pharmaceuticals, Tucson, Arizona, United States of America
⨯ -
Alyssa VanderWerff,
Affiliation Helen DeVos Children’s Hospital, Grand Rapids, Michigan, United States of America
⨯ -
Takamaru Ashikaga,
Affiliation Medical Biostatistics, University of Vermont, Burlington, Vermont, United States of America
⨯ -
Jeffrey P. Bond,
Affiliation Department of Microbiology and Molecular Genetics, University of Vermont College of Medicine, Burlington, Vermont, United States of America
⨯ -
William Ferguson,
Affiliation Cardinal Glennon Children's Hospital, St. Louis, Missouri, United States of America
⨯ -
William Roberts,
Affiliation University of California San Diego School of Medicine and Rady Children's Hospital, San Diego, California, United States of America
⨯ -
Randal K. Wada,
Affiliation Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States of America
⨯ -
Don Eslin,
Affiliation Arnold Palmer Hospital for Children, Orlando, Florida, United States of America
⨯ -
Jacqueline M. Kraveka,
Affiliation Medical University of South Carolina, Charleston, South Carolina, United States of America
⨯ -
Joel Kaplan,
Affiliation Levine Children's Hospital, Charlotte, North Carolina, United States of America
⨯ -
Deanna Mitchell,
Affiliation Helen DeVos Children’s Hospital, Grand Rapids, Michigan, United States of America
⨯ -
Nehal S. Parikh,
Affiliation Connecticut Children's Medical Center, Hartford, Connecticut, United States of America
⨯ -
Kathleen Neville,
Affiliation Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States of America
⨯ -
Leonard Sender,
Affiliation Children’s Hospital of Orange County, Orange, California, United States of America
⨯ -
Timothy Higgins,
Affiliation Medical Biostatistics, University of Vermont, Burlington, Vermont, United States of America
⨯ -
Masao Kawakita,
Affiliation Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
⨯ -
Kyoko Hiramatsu,
Affiliation Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
⨯ -
Shun-suke Moriya,
Affiliation Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
⨯ - [ ... ],
-
André S. Bachmann
* E-mail: giselle.sholler@helendevoschildrens.org (GS) or andre.bachmann@hc.msu.edu (AB)
Affiliations College of Human Medicine, Michigan State University, Grand Rapids, Michigan, United States of America, University of Hawaii at Hilo, The Daniel K. Inouye College of Pharmacy, Hilo, Hawaii, United States of America
⨯ - [ view all ]
- [ view less ]
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma
- Giselle L. Saulnier Sholler,
- Eugene W. Gerner,
- Genevieve Bergendahl,
- Robert B. MacArthur,
- Alyssa VanderWerff,
- Takamaru Ashikaga,
- Jeffrey P. Bond,
- William Ferguson,
- William Roberts,
- Randal K. Wada
- Published: May 27, 2015
- https://doi.org/10.1371/journal.pone.0127246